Bernard GR - Search Results

1

Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.

Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP, Ehrenfeld JM, Byrne DW, Stollings JL, Siew ED, Bernard GR, Self WH, Rice TW, Semler MW. Brown RM, et al. Among authors: bernard gr. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1487-1495. doi: 10.1164/rccm.201903-0557OC. Am J Respir Crit Care Med. 2019. PMID: 31454263 Free PMC article. Clinical Trial.

2

Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis.

Bernard G, Artigas A, Dellinger P, Esmon C, Faist E, Faust SN, Fischer CJ, Fumagalli R, grinnell BW, Sprung C. Bernard G, et al. Crit Care Med. 2001 Jul;29(7 Suppl):S75-7. doi: 10.1097/00003246-200107001-00025. Crit Care Med. 2001. PMID: 11445738 Review. No abstract available.

3

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.

Bernard GR. Bernard GR. Crit Care Med. 2003 Jan;31(1 Suppl):S85-93. doi: 10.1097/00003246-200301001-00012. Crit Care Med. 2003. PMID: 12544981 Review.

4

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators. Ely EW, et al. Among authors: bernard gr. Crit Care Med. 2003 Jan;31(1):12-9. doi: 10.1097/00003246-200301000-00002. Crit Care Med. 2003. PMID: 12544987 Clinical Trial.

5

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis.

Bernard GR, Macias WL, Joyce DE, Williams MD, Bailey J, Vincent JL. Bernard GR, et al. Crit Care. 2003 Apr;7(2):155-63. doi: 10.1186/cc2167. Epub 2003 Feb 28. Crit Care. 2003. PMID: 12720562 Free PMC article. Review.

6

Costs associated with delirium in mechanically ventilated patients.

Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Milbrandt EB, et al. Among authors: bernard gr. Crit Care Med. 2004 Apr;32(4):955-62. doi: 10.1097/01.ccm.0000119429.16055.92. Crit Care Med. 2004. PMID: 15071384

7

Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock.

Rice TW, Bernard GR. Rice TW, et al. Among authors: bernard gr. Am J Med Sci. 2004 Oct;328(4):205-14. doi: 10.1097/00000441-200410000-00003. Am J Med Sci. 2004. PMID: 15486535 Review.

8

The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.

Angus DC, Laterre PF, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR; PROWESS Investigators. Angus DC, et al. Among authors: bernard gr. Crit Care Med. 2004 Nov;32(11):2199-206. doi: 10.1097/01.ccm.0000145228.62451.f6. Crit Care Med. 2004. PMID: 15640631 Free PMC article.

9

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.

Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Parsons PE, et al. Among authors: bernard gr. Crit Care Med. 2005 Jan;33(1):1-6; discussion 230-2. doi: 10.1097/01.ccm.0000149854.61192.dc. Crit Care Med. 2005. PMID: 15644641 Clinical Trial.

10

Therapeutic intervention and targets for sepsis.

Rice TW, Bernard GR. Rice TW, et al. Among authors: bernard gr. Annu Rev Med. 2005;56:225-48. doi: 10.1146/annurev.med.56.082103.104356. Annu Rev Med. 2005. PMID: 15660511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page